Norwegian Mental Illness Heart Health Study
Recruiting
N/A
Interventional Study
Cardio Vascular Disease
Metabolic Syndrome (MetS)
Severe Mental Disorder
Schizophrenia and Schizophrenia Spectrum Psychosis
Bipolar Disease Type I
Overweight and/or Obesity
CVD Risk Factors
Severe Mental Illness
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 25 – 70
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 70 (estimated)
- Sponsor
- Madeleine Elisabeth Angelsen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Norwegian patients with severe mental illnesses (SMI), such as schizophrenia spectrum or bipolar disorder, lose on average 10 years of life compared to mentally healthy individuals. Much of this gap is due to heart disease. Unhealthy lifestyle habits, including poor diet and physical inactivity, contribute to higher levels of metabolic risk factors for heart disease in this population.
The goal o…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of F20-29 (schizophrenia spectrum) or F31 (bipolar affective disorder)
* Current use of antipsychotic medication (first- or second generation) or lithium
* Body Mass Index \> or = 27 kg/m\^2
Exclusion Criteria:
Psychiatric condition:
* Inability to provide informe…
Contacts